Trupanion, Inc. (NASDAQ:TRUP – Get Free Report) EVP Steve Weinrauch sold 6,674 shares of the stock in a transaction that occurred on Friday, June 5th. The shares were sold at an average price of $22.00, for a total transaction of $146,828.00. Following the sale, the executive vice president directly owned 78,062 shares of the company’s stock, valued at approximately $1,717,364. This represents a 7.88% decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link.
Trupanion Stock Down 0.4%
TRUP stock opened at $23.29 on Friday. Trupanion, Inc. has a 12 month low of $21.16 and a 12 month high of $57.88. The firm has a market cap of $1.02 billion, a PE ratio of 39.47 and a beta of 1.45. The firm has a 50 day simple moving average of $24.29 and a 200 day simple moving average of $29.33. The company has a debt-to-equity ratio of 0.25, a current ratio of 1.73 and a quick ratio of 1.73.
Trupanion (NASDAQ:TRUP – Get Free Report) last released its earnings results on Thursday, April 30th. The financial services provider reported $0.11 EPS for the quarter, beating the consensus estimate of $0.07 by $0.04. Trupanion had a net margin of 1.74% and a return on equity of 6.87%. The business had revenue of $384.05 million during the quarter, compared to analyst estimates of $379.77 million. During the same period in the prior year, the business earned ($0.03) earnings per share. The business’s quarterly revenue was up 12.3% on a year-over-year basis. Equities research analysts forecast that Trupanion, Inc. will post 0.53 earnings per share for the current fiscal year.
Institutional Investors Weigh In On Trupanion
Wall Street Analyst Weigh In
Several equities research analysts recently commented on TRUP shares. Weiss Ratings restated a “sell (d+)” rating on shares of Trupanion in a research report on Monday, June 1st. Zacks Research downgraded shares of Trupanion from a “strong-buy” rating to a “hold” rating in a research report on Friday, February 13th. Cantor Fitzgerald reduced their price target on shares of Trupanion from $42.00 to $34.00 and set a “neutral” rating for the company in a research report on Thursday, April 9th. Stifel Nicolaus reduced their price target on shares of Trupanion from $35.00 to $31.00 and set a “hold” rating for the company in a research report on Tuesday, March 31st. Finally, Piper Sandler reduced their price target on shares of Trupanion from $60.00 to $45.00 and set an “overweight” rating for the company in a research report on Friday, February 13th. Two analysts have rated the stock with a Buy rating, three have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat.com, Trupanion presently has a consensus rating of “Hold” and an average price target of $42.25.
View Our Latest Stock Analysis on TRUP
Trupanion Company Profile
Trupanion, Inc is a pet medical insurance company that provides comprehensive insurance coverage for cats and dogs. The company’s core offering is a single, customizable medical policy designed to cover veterinary diagnostic tests, surgeries, hospital stays and congenital or hereditary conditions. Trupanion seeks to streamline the claims process by offering direct payment options to participating veterinarians, reducing the need for upfront payments by pet owners.
Founded in 1999 by Darryl Rawlings and headquartered in Seattle, Washington, Trupanion began operations in the early 2000s and has grown its presence through both digital channels and partnerships with veterinary hospitals.
Further Reading
- Five stocks we like better than Trupanion
- Microsoft Just Gave Investors 3 Dates They Can’t Afford to Ignore
- NVIDIA’s Outlook Gains Momentum: Stock Price to Follow
- The World Cup Is Coming—These 3 Stocks Could Cash In
- Spotify’s “North Star” Outlook Was Music to Investors Ears
Receive News & Ratings for Trupanion Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Trupanion and related companies with MarketBeat.com's FREE daily email newsletter.
